Local anesthetics 2

29
Local Anesthetics (LAs) By: Seyoum Gizachew (B. Pharm., MSc.)

description

ddddd

Transcript of Local anesthetics 2

Page 1: Local anesthetics  2

Local Anesthetics (LAs)

By: Seyoum Gizachew (B. Pharm., MSc.)

Page 2: Local anesthetics  2

2

Introduction

Defn.

• Local anesthesia is the loss of sensation in a body part without

the loss of consciousness or the impairment of central control of

vital functions.

• Two major advantages.

– physiological perturbations associated with general anesthesia

are avoided; and

– neurophysiological responses to pain and stress can be

modified beneficially.

• Local anesthetics potentially can produce deleterious side effects.

– Proper choice and care in its use are the primary determinants

in avoiding toxicity.

Page 3: Local anesthetics  2

3

Chemistry

• The typical local anesthetics contain: – hydrophilic and hydrophobic moieties that are separated

by an intermediate ester or amide linkage. • Compounds containing these minimal structural features can

satisfy the requirements for action as local anesthetics. • The hydrophilic group usually is a tertiary amine but also

may be a secondary amine.• The hydrophobic moiety must be aromatic (benzene ring).• The intermediate chain has either;– ester linkage from an aromatic acid and an amino alcohol

or – amide linkage from an aromatic amine and an amino acid.

Page 4: Local anesthetics  2

4

Chemistry cont…

Figure: Model Structure of local anesthetics showing aromatic portion, intermediate chain, and amine portion.

Page 5: Local anesthetics  2

5

Chemistry cont…

• Can be classified as esters or amides, – based on the structure of this intermediate chain.

• The nature of the linking group determines some of the pharmacological properties of these agents.

• For example, local anesthetics with an ester link are hydrolyzed readily by plasma esterases.

Page 6: Local anesthetics  2

6

Mechanism of Action

• Conduction of nerve impulses is mediated by action potential (AP) generation along axon.

• Cationic form of local anesthetic binds at inner surface of Na+ channel – preventing Na+ influx (rising phase of membrane potential) which initiates AP → blockade of nerve impulses (e.g., those mediating pain).

Page 7: Local anesthetics  2

7Figure: Sodium channel

Mechanism of action cont…

Page 8: Local anesthetics  2

8

Mechanism of action cont…

Page 9: Local anesthetics  2

9

Classification of LAs

Esters• Cocaine, Butacaine, Tetracaine, Procaine, Benzocaine,

Chloroprocaine, Propoxycaine

Amides • Articaine, Bupivacaine, Dibucaine, Etidocaine, Lidocaine,

Mepivacaine, Prilocaine, Ropivacaine

Page 10: Local anesthetics  2

10

Pharmacokinetic Properties

Absorption and Distribution• Rate of absorption is affected by:– The dose administered, – The vascularity at the site of injection, and – The specific physicochemical properties of the drug itself.

• All tissues will be exposed to LAs after absorption, but concentration of LAs vary among tissues.

• Highly perfused organs (i.e., brain, kidney, and lung) will have highest concentration.

• Degree of protein binding and lipid solubility also affect drug distribution.

Page 11: Local anesthetics  2

11

Absorption and Dist. cont…

• Placental transfer is known to occur rapidly.– fetal blood concentrations generally reflecting those

found in the mother. • However, the quantity of drug crossing to the fetus is also

related to the time of exposure. – i.e. from the time of injection to delivery (during labor).

• Rapidly hydrolyzed LAs (esters) such as chloroprocaine used in obstetrics.

Page 12: Local anesthetics  2

12

Metabolism of LAs• Depends on the linkage a LA has (either an ester or an

amide).• Esters are extensively and rapidly metabolized in plasma by

pseudocholinesterase, whereas the amide linkage is resistant to hydrolysis.

Esters Plasma cholinesterases

Amides CytP450

Page 13: Local anesthetics  2

13

Metabolism cont…

• Rate of LA hydrolysis is important,– slow biotransformation may lead to drug accumulation and

toxicity. • Patients with atypical plasma cholinesterase,– ester linked compounds (chloroprocaine, procaine and

tetracaine) increased potential for toxicity. • Formation of paraaminobenzoic acid (PABA), from ester-

linked LAs.– known to be allergenic to some people.

• LA with an amide linkage are almost completely metabolized by the liver before excretion.

Page 14: Local anesthetics  2

14

Clinical Uses of LAs• LAs are extremely useful in a wide range of procedures,

varying from intravenous catheter insertion to extensive surgery under regional block.

• For minor surgery, the patients can remain awake;– an advantage in emergency surgery,

• Many operative procedures in the oral cavity. – If surgery permits, the patient can return home.

• Topical Anesthesia• Infiltration• Regional Block• Spinal Anesthesia (subarachnoid block)• Epidural Anesthesia• Caudal Anesthesia

Page 15: Local anesthetics  2

15

Page 16: Local anesthetics  2

16

Page 17: Local anesthetics  2

17

Page 18: Local anesthetics  2

18Epidural Anesthesia

Page 19: Local anesthetics  2

19

Page 20: Local anesthetics  2

20

Page 21: Local anesthetics  2

21

Page 22: Local anesthetics  2

22

Page 23: Local anesthetics  2

23Caudal Anesthesia

Page 24: Local anesthetics  2

24

Control of Cardiac Arrhythmias• Procainamide and lidocaine are two of the primary drugs for treating

cardiac arrhythmias. • Since lidocaine has a short duration of action, it is common to

administer it by continuous infusion. • Procainamide, because of its amide linkage, has longer action than

does its precursor, procaine.

Symptomatic ventricular tachycardia treatment.• For Acute termination:

First line:– Lidocaine 1-1.5 mg/kg I.V. can be repeated with in 3 min to a

maximum of 3mg/kg.

Alternative:• Procainamide, 25-50 mg I.V. over one minute period then repeated

every 5 min until the arrhythmia is controlled, hypotension results, or the QRS complex is prolonged more than 50%.

Page 25: Local anesthetics  2

25

Use of Vasoconstrictors

• Vasoconstrictors (commonly sympathomimetic drugs), are often added to LA to delay absorption from the injection site.

• By slowing absorption, these drugs reduce the anesthetic’s systemic toxicity and keep it in contact with nerve fibers longer, thereby increasing the drug’s duration of action.

• Administration of lidocaine 1% with epinephrine results in the same degree of blockade as that produced by lidocaine 2% without the vasoconstrictor.

Epinephrine:• By far the most commonly employed. • precaution is needed when LAs containing this amine are

given to a patient with hypertension or an irritable myocardium.

Page 26: Local anesthetics  2

26

Adverse Effects of LAs

• CNS and cardiopulmonary systems are most commonly affected by high plasma levels of LAs.

• LAs given in initially high doses produce CNS stimulation:– restlessness, disorientation, tremors, and at times clonic

convulsions. – Continued exposure to high concentrations results in

general CNS depression; death occurs from respiratory failure.

– Treatment requires ventilatory assistance and drugs to control the seizures (ultra-short acting barbiturates, benzodiazepines).

• CNS manifestations generally occur before cardiopulmonary collapse.

Page 27: Local anesthetics  2

27

Adverse Effects cont…

• Cardiac toxicity:– result of drug induced depression of cardiac conduction

(e.g., atrioventricular block, intraventricular conduction block) and systemic vasodilation.

– may progress to severe hypotension and cardiac arrest. • Allergic reactions:– with the ester type local anesthetics (PABA).

Page 28: Local anesthetics  2

28

Esters

Chloroprocaine• Obtained from addition of a chlorine atom to procaine, – greater potency and less toxicity than procaine itself.

• Hydrolyzed very rapidly by cholinesterase – short plasma half-life. • commonly used in obstetrics.

Page 29: Local anesthetics  2

29

Amides

Lidocaine HCl• The most commonly used local anesthetic. • well tolerated• Infiltration and regional nerve blocks. • Also commonly used for spinal and topical anesthesia and as

an antiarrhythmic agent.• Has a more rapidly occurring, more intense, and more

prolonged duration of action than does procaine.• Metabolized by Liver (CYP 1A2, CYP 3A4)• Dose: 5 to 10 ml of 2% lidocaine (max. 300 mg/dose)